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One-pot synthesis of 2-aryl benzothiazoles from gem-dibromomethylarenes using 2-aminoarylthiols is
described. Benzothiazoles were obtained in high chemical yields under mild conditions. This transforma-
tion would facilitate synthesis by short reaction times, large-scale synthesis, easy and quick isolation of
the products, which are the main advantages of this procedure.
 2011 Published by Elsevier Ltd.Br H2N Pyridine / t-BuOK N
R RThe exploration of privileged structures in drug discovery is a
rapidly emerging area in medicinal chemistry. These structures
represent a class of molecules capable of binding to multiple recep-
tors with high afﬁnity. By probing into these molecules, it enables
the medicinal chemist to rapidly discover biologically active
compounds across a wide range of therapeutic areas within a rea-
sonable time scale. The substituted 2-arylbenzothiazoles have
emerged in recent years as an important pharmacophore in a num-
ber of diagnostic and therapeutic settings and attractive features of
drug candidates based on this benzothiazole scaffold include their
synthetic accessibility as imaging agents for b-amyloid, antitumor
agents, calcium channel antagonists, antituberculotics, antiparasi-
tics, chemiluminescent agents and also as photosensitizers.1–7
A number of recent variants on the traditional solvent-based
thermal synthetic conditions have been reported. For example,
the classic methods for the synthesis of 2-aryl benzothiazoles are
the condensation of o-aminothiophenol with aromatic carboxylic
acids,8 or aromatic aldehydes, followed by the oxidation with
strong oxidants, such asmolecular O2,9 H2O2,10 MnO2,11 and co-oxi-
dant DMSO12 as described. We herein describe a new, efﬁcient and
straightforward approach starting from gem-dibromomethylarenes
using o-aminobenzenethiols in the absence of strong oxidants, and
this tandem process involving cyclization and aromatization, fur-
nished 2-aryl benzothiazoles in high yields.Elsevier Ltd.
appa).The substitution of carboxylic acid or aldehyde component with
an alternative functional group has not been explored so far. There-
fore, the development of a simple and stable substitute for these
aromatic acids or aldehydes by using gem-dihalomethylarenes
would extend the scope of the reaction in organic synthesis. Re-
cently, gem-dihalomethylarenes have received considerable atten-
tion due to their application in the preparation of aldehydes,13 the
use of gem-dihalomethylarenes is limited to the synthesis of alde-
hydes and a,b-unsaturated carboxylic acids and esters.14,15
In continuation of our work16 on the development of useful syn-
thetic methodologies from gem-dibromomethylarenes, in this
study we wish to report the one-step conversion of gem-dibro-
momethylarenes into the corresponding benzothiazoles by using
aminobenzenethiols, potassium tertiary butoxide (t-BuOK) and
catalytic amount of iodine in pyridine at reﬂux conditions with
excellent yields (Scheme 1).17,18
In the preliminary stage of investigation we focused on the sys-
tematic evaluation of different base catalysts for themodel reaction
of gem-dibromomethylarenes and o-aminobenzenethiols at reﬂux
conditions in pyridine. A wide variety of base catalysts including
DBU, triethylamine, DABCO, K2CO3, Cs2CO3, and piperidine wereAr
Br HS I2 , Reflux / 2 h
S
Ar
1 2 3(a-r)
Scheme 1. General approach to synthesis of 2-arylbenzothiazoles.
Table 1
Synthesis of benzothiazoles from gem-dibromomethlarenes using 2-amino benzenethiols
Entry Substratea 2-Aminobenzene thiols (R) Product Time (h) Yieldb (%)
1
Br
Br
1a
R = H
2a S
N
3a
1.5 92
2 1a
R = CF3
2b S
N CF3
3b
2 86
3 1a
R = Cl
2c S
N Cl
3c
2 83
4
N
Br
Br
Br
1b
2a
S
N
N
Br
3d
2 87
5 1b 2b S
N
N
Br
CF3
3e
2 90
6 1b 2c S
N
N
Br
Cl
3f
2 85
7
Br
Br
Br
1c
2a S
N
Br
3g
2 82
8 1c 2b
S
N
Br
CF3
3h
2 85
9 1c 2c
S
N
Br
Cl
3i
2 77
10
Br
Br
O2N
Br
1d
2a S
N
O2N
Br
3j
2 82
11 1d 2b S
N
O2N
Br
CF3
3k
2 83
12 1d 2c S
N
O2N
Br
Cl
3l
2 86
(continued on next page)
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Table 1 (continued)
Entry Substratea 2-Aminobenzene thiols (R) Product Time (h) Yieldb (%)
13
Br
Br
Br
Cl
1e
2a
S
N
Br
Cl
3m
2 81
14 1e 2b
S
N
Br
Cl
CF3
3n
2 85
15 1e 2c
S
N
Br
Cl
Cl
3o
2 81
16 S
Br
BrBr
1f
2a S
N
SBr
3p
2 77
17 1f 2b S
N
SBr
CF3
3q
2 80
18 1f 2c S
N
SBr
Cl
3r
2 75
a Substrates are prepared from the commercial methyl analogs by radical bromination.
b Isolated yields.
Ar
Br
Br
H2N
HO
Pyridine / t-BuOK
I2 , Reflux / 2 h O
N
Ar
1 4 5
Yield, 25 %
Scheme 2. Synthesis of 2-phenylbenzoxazole.
5476 C. Siddappa et al. / Tetrahedron Letters 52 (2011) 5474–5477employed to improve the yield for the speciﬁc synthesis of 2-aryl
benzothiazoles. While piperidine catalysed the reaction to give
quantitative yield in 4–5 h, the other bases did not promote this
reaction. Interestingly, when the reaction was carried out in the
presence of t-BuOK, it led to the desired product in high yields in
1.5–2.0 h; the results were tabulated in Table 1.
The synthetic approach starting from the corresponding com-
mercially available methyl analogs using radical bromination is
well documented.13 Our approach was initiated using a mixture
of gem-dibromomethylarenes (1.0 equiv) 1 and aminobenzenethi-
ols (1.1 equiv) 2 with anhydrous pyridine in the presence of a t-
BuOK (0.5 equiv) followed by the addition of iodine (0.2 equiv)
and reﬂuxing at 90 C for 2 h. The starting material was consumed
in 2 h as indicated by TLC analysis and the results are presented in
Table 1. This transformation would extend the scope in organic
synthesis, in addition, it is interesting to note that both aromatic
and heteroaromatic gem-dibromomethylarenes bearing various
functionalities such as chloro, bromo, nitro, and triﬂuoro methyl
groups survived the reaction and provided high yields of corre-
sponding benzothiazoles. The reaction was further probed bytreating gem-dibromomethylarenes 1 with o-aminophenol 4 using
the same procedure as described in Scheme 1 to obtain 2-phenyl-
benzoxazole (Scheme 2) in a very low yield (25%). Hence, o-amino-
phenol was not a good substrate for this protocol.
In summary, this one-step reaction presents an efﬁcient method
to convert gem-dibromomethylarenes to 2-aryl benzothiazoles.
The mild reaction conditions offer the potential for the use of this
method in the synthesis of complex molecules. It is anticipated
that this methodology will have versatile applications in the prac-
tical syntheses of biologically important pharmaceutical molecules
with benzothiazole moiety.Acknowledgement
The authors are grateful to UGC, Govt. of India for ﬁnancial sup-
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